| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9313375 | Urology | 2005 | 6 Pages |
Abstract
Ligands for PPARγ have multiple antitumor effects in human RCC cells in vitro. Activation of the PPARγ pathway may be a new strategy for treatment of patients with RCC.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Jinyang Yuan, Atsushi Takahashi, Naoya Masumori, Kohsuke Uchida, Shin-Ichi Hisasue, Hiroshi Kitamura, Naoki Itoh, Taiji Tsukamoto,